Indeed, overexpression of miR-1915-3p, the level of which is increased in BC patients compared with healthy volunteers, determined a reduction of the target gene DUSP3 while increasing the phosphorylation of ERK1/2. The gene discussed is MAPK3; the disease is breast cancer.